Annam Biosciences Competitors and Similar CompaniesClear all
GlycoMimetics's competitors and similar companies include Xynomic Pharmaceuticals.
 GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Xynomic Pharmaceuticals Xynomic Pharmaceuticals is a clinical-stage oncology therapeutics biopharmaceutical company developing oncology drugs. | |
Founding Date | Founding Date 2003 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Rockville, US HQ | Locations Dover, US HQ Poway, US |
Employees | Employees 5025% increase | Employees 25 |
Valuation ($) | Valuation ($) 31.6 m | Valuation ($) 102.7 m |
Financial | ||
Net income | Net income ($153.9m) (FY, 2025) | Net income ($25.1m) (FY, 2019) |
Funding | ||
Total funding raised | Total funding raised $ 101.8m | Total funding raised $ 4.8m |
For sources of this data, please see the company profile
View Company Profiles
Xynomic Pharmaceuticals
HQ
Dover, US
Employees
25
Xynomic Pharmaceuticals is a clinical-stage oncology therapeutics biopharmaceutical company developing oncology drugs.
View company